Erythropoietin-induced rheological changes of rat erythrocytes

被引:23
|
作者
Bor-Kucukatay, M
Yalcin, O
Meiselman, HJ
Baskurt, OK [1 ]
机构
[1] Akdeniz Univ, Sch Med, Dept Physiol, Antalya, Turkey
[2] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA
关键词
erythropoietin; erythrocyte deformability; erythrocyte aggregation; cell electrophoresis; surface charge density;
D O I
10.1046/j.1365-2141.2000.02150.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of recombinant human erythropoietin (rhEPO) on red blood cell (RBC) rheological properties were investigated in rats. Rats received intramuscular injections of 150 U/kg/d rhEPO for 5 d, following which blood samples were obtained 1, 5 or 10 d later. RBC deformability was assessed by determining cell transit times through 5-mu m micropores (CTA) and RBC shape recovery time constants via photometry, aggregation in plasma and dextran was measured by photometry and RBC electrophoretic mobility was determined in a cylindrical electrophoresis system. RBC aggregation was found to be significantly decreased on day 5 after rhEPO treatment (P < 0.05), yet was unchanged from control on days 1 and 10. Mean RBC micropore transit times remained unchanged, but the distributions of transit times were altered; compared with control, the 5th percentiles on both days 1 and 5 were decreased and the 95th percentile on day 1 was elevated. Electrophoretic mobility of RBCs in phosphate-buffered saline was significantly increased on day 5 after rhEPO treatment (P < 0.05), with mobility measurements in dextran 500 (MW = 500 kDa) solutions suggesting that the cells' surface properties related to the formation of a 'depletion layer' may be altered on day 1. These results indicate that the rheological behaviour of RBC as a consequence of rhEPO treatment are temporal and are affected by the presence of reticulocytes as well as by the average age of the circulating cells.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 50 条
  • [1] ERYTHROPOIETIN-INDUCED CHANGES IN PLASMA CALCIUM AND BONE-MARROW MITOSIS IN RAT
    HUNT, NH
    PERRIS, AD
    JOURNAL OF ENDOCRINOLOGY, 1973, 56 (01) : 47 - 57
  • [2] Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart
    Garg, Kavita
    Yadav, Harlokesh N.
    Singh, Manjeet
    Sharma, P. L.
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (04) : 219 - 223
  • [3] Mechanism of erythropoietin-induced hypertension
    Vaziri, ND
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (05) : 821 - 828
  • [4] PHLEBOTOMY FOR ERYTHROPOIETIN-INDUCED MALIGNANT HYPERTENSION
    FAHAL, IH
    YAQOOB, M
    AHMAD, R
    NEPHRON, 1992, 61 (02) : 214 - 216
  • [5] SEROTONERGIC MECHANISM OF ERYTHROPOIETIN-INDUCED HYPERTENSION
    AZZADIN, A
    BIALKOWSKA, A
    BUCZKO, W
    MALYSZKO, J
    KALINOWSKI, M
    MYSLIWIEC, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (08) : 882 - 883
  • [6] Erythropoietin-induced epilepsy in hemodialysis patients?
    Beccari, M
    NEPHRON, 1998, 78 (03): : 354 - 354
  • [7] Circulating adrenomedullin in erythropoietin-induced hypertension
    Kuriyama, S
    Kobayashi, H
    Tomonari, H
    Tokudome, G
    Hayashi, F
    Kaguchi, Y
    Horiguchi, M
    Ishikawa, M
    Hosoya, T
    HYPERTENSION RESEARCH, 2000, 23 (05) : 427 - 432
  • [8] Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells
    Kaneda, Tae
    Tsuruoka, Shuichi
    Fujimura, Akio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 649 (1-3) : 38 - 43
  • [9] Early events in erythropoietin-induced signaling
    Damen, JE
    Krystal, G
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (13) : 1455 - 1459
  • [10] RHEOLOGICAL PROPERTIES OF ERYTHROCYTES IN RECOMBINANT HUMAN ERYTHROPOIETIN-ADMINISTERED NORMAL RAT
    MAEDA, N
    KON, K
    TATEISHI, N
    SUZUKI, Y
    SEKIYA, M
    TANIGUCHI, T
    SEIKE, M
    NAKAJIMA, T
    SHIGA, T
    TANAKA, K
    SHINKURA, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) : 105 - 111